Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment-A Single-Group Repeated-Measures Trial.

Mengnan LiXifeng YangRu LiBaofeng WuJinxuan HaoYijie QiTao BaiLuyang YangYi ZhangYunfeng Liu

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)

After anti-thyroid medicine treatment, patients had elevated visceral fat area and subcutaneous fat area and altered lipid profiles. These changes may be one of the reasons why metabolic and cardiovascular diseases remain increased after thyroid function is restored.

Keyphrases

end stage renal disease
adipose tissue
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
peritoneal dialysis
metabolic syndrome
patient reported outcomes
coronary artery disease
patient reported